A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With Eprosartan


Phase N/A Results

Summary of Purpose

The primary objective of the study is to evaluate the proportion of hypertensive patients who achieve regulation of their blood pressure (BP) levels according to the European Society of Cardiology / European School of Haematology (ESC/ESH) Guidelines, after treatment with eprosartan for 6 months under standard medical practice conditions. The absolute change in Systolic blood pressure from baseline will also be...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 August 2014.

1 Mar 2012 16 Mar 2012 1 Mar 2013 1 Mar 2013 1 Aug 2014 27 Mar 2014
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



Trial Design

  • Perspective: Prospective
  • Sampling: Non-Probability Sample